(주)메디이미지

RESOURCES

혈력(SIG) 바이오마커와 VINT 기술을 기반으로

국내외 학술 저널에 다수의 연구 논문을 발표하고

핵심 특허를 보유하여 뇌혈관 진단의 새로운 표준을

만들어가고 있습니다.

mobile background

(주)메디이미지

RESOURCES

혈력(SIG) 바이오마커와 VINT 기술을 기반으로 국내외 학술 저널에 다수의 연구 논문을 발표하고

핵심 특허를 보유하여 뇌혈관 진단의 새로운 표준을 만들어가고 있습니다.

PaperDirect Assessment of Wall Shear Stress by Signal Intensity Gradient from Time-of-Flight Magnetic Resonance Angiography

2025-01-21
조회수 68

저자

Kap-Soo Han, Sang Hyuk Lee, Han Uk Ryu, Se-Hyoung Park, Gyung-Ho Chung, Young I Cho, Seul-Ki Jeong.



개제일

2017년 8월 16일



키워드

Wall Shear Stress, Signal Intensity Gradient, Time-of-Flight Magnetic Resonance Angiography



Abstract


The aim of the study was to calculate the arterial wall signal intensity gradient (SIG) from time-of-flight MR angiography (TOF-MRA) and represent arterial wall shear stress.

We developed a new algorithm that uses signal intensity (SI) of a TOF-MRA to directly calculate the signal intensity gradient (SIG).

The results from our phantom study showed that the TOF-MRA SIG could be used to distinguish the magnitude of blood flow rate as high (mean SIG ± SD, 2.2 ± 0.4 SI/mm for 12.5 ± 2.3 L/min) and low (0.9 ± 0.3 SI/mm for 8.5 ± 2.6 L/min) in vessels (p < 0.001).

Additionally, we found that the TOF-MRA SIG values were highly correlated with various flow rates (β = 0.96, p < 0.001). Remarkably, the correlation coefficient between the WSS obtained from the computational fluid dynamics (CFD) analysis and the TOF-MRA SIG was greater than 0.8 in each section at the carotid artery (p < 0.001 for all β values).

This new technique using TOF-MRA could enable the rapid calculation of the TOF-MRA SIG and thereby the WSS. Thus, the TOF-MRA SIG can provide clinicians with an accurate and efficient screening method for making rapid decisions on the risk of vascular disease for a patient in clinical practice.


+ 자세히 보기




(주)메디이미지|Est.2018

사업자등록번호 : 313-87-00931 

본  사 : 서울 마포 SBA 허브 508호

연구소 : 경기 분당 서울대병원 헬스케어 이노베이션 파크 2층 6호

TEL : (+82) 02-484-5773 | FAX : (+82) 02-6499-6448 

E-mail : info@mediimg.com

FDA 510K 승인일 : 2024.10.15

Copyright © 2025 (주)메디이미지 All rights reserved.


식품의약품안전처

승인완료

(주)메디이미지|Est.2018

사업자등록번호 : 313-87-00931 

본  사 : 서울 마포 SBA 허브 508호|연구소 : 경기 분당 서울대병원 헬스케어 이노베이션 파크 2층 6호

TEL : (+82) 02-484-5773 | FAX : (+82) 02-6499-6448  | E-mail|info@mediimg.com

FDA 510K 승인일 : 2024.10.15

식품의약품안전처

승인완료


Copyright © 2025 (주)메디이미지 All rights reserved.